Related Experiment Videos
Aloesin inhibits hyperpigmentation induced by UV radiation.
1Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea. choiswsw@hotmail.com
Clinical and Experimental Dermatology
|October 10, 2002
Summary
Aloesin effectively inhibits skin hyperpigmentation caused by UV radiation by suppressing melanin production. This natural compound shows promising potential as a topical agent for preventing UV-induced skin darkening.
Area of Science:
- Dermatology
- Biochemistry
- Photobiology
Background:
- Skin hyperpigmentation results from excessive melanin production, primarily driven by tyrosinase activity.
- Aloesin has been previously identified as a tyrosinase inhibitor.
Purpose of the Study:
- To evaluate the efficacy of aloesin in inhibiting UV-induced skin pigmentation in humans.
- To compare the effects of aloesin with arbutin, a known skin-lightening agent.
Main Methods:
- Human subjects received controlled UV irradiation on their forearms.
- Treated areas were assigned to vehicle control, aloesin, arbutin, or a combination of aloesin and arbutin.
- Aloesin and/or arbutin were applied topically four times daily for 15 days.
Main Results:
- Aloesin treatment reduced pigmentation by 34%, while arbutin reduced it by 43.5%.
- Combined treatment with aloesin and arbutin achieved a 63.3% reduction in pigmentation compared to the control.
- Aloesin demonstrated dose-dependent suppression of pigmentation.
Conclusions:
- Aloesin significantly inhibits UV-induced melanin formation in human skin.
- Aloesin, alone or in combination with arbutin, presents a viable strategy for managing skin hyperpigmentation.
- Further research into aloesin as a photoprotective and skin-lightening agent is warranted.